Common ELF1 deletion in prostate cancer bolsters oncogenic ETS function, inhibits senescence and promotes docetaxel resistanceJustin A. Budka, Peter C. Hollenhorst, Mary W. Ferris et al.|Genes & Cancer|2018Cited by 40